Dendritic cells transduced with autoantigen FCRLA induce cytotoxic lymphocytes and vaccinate against murine B-cell lymphoma. 2007

Takashi Inozume, and Hiroshi Mitsui, and Takashi Okamoto, and Yuriko Matsuzaki, and Yutaka Kawakami, and Naotaka Shibagaki, and Shinji Shimada
Faculty of Medicine, Department of Dermatology, University of Yamanashi, Yamanashi, Japan.

We previously reported early evidence of the human Fc receptor-like A (hFCRLA), an antigen (Ag) that was specifically expressed in melanocytes, melanoma cells, and some B-cell states, and was recognized by IgG antibodies from melanoma patients. Recently, it has been demonstrated that hFCRLA is expressed in most human B-cell lymphoma tissues. In this report, we investigated the potential of FCRLA as a tumor-associated Ag of B-cell lymphoma for immunotherapy. We confirmed that murine FCRLA (mFCRLA) was expressed and distributed in murine tissues similar to hFCRLA. Recombinant mFCRLA fusion protein was constructed with a polyarginine (R9)-protein-transduction domain (PTD) (rR9-HA-mFCRL), and was transduced into bone marrow-derived dendritic cells (DC) ex vivo. Mice immunized with rR9-HA-mFCRL-treated DC primed cytotoxic T-lymphocyte (CTL) that killed the B-cell lymphoma cell line (A20), which express mFCRLA abundantly. In a tumor challenging study, A20 tumor growth inoculated in skin was significantly suppressed in mice vaccinated with rR9-HA-mFCRL-treated DC, compared with control mice. These results indicated that FCRLA is a potential target Ag in immunotherapy for B-cell lymphoma. In addition, our experimental system using R9-PTD-containing full-length proteins might be a useful method to analyze the immunogenicity of novel candidates of tumor-associated Ags in vivo.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens

Related Publications

Takashi Inozume, and Hiroshi Mitsui, and Takashi Okamoto, and Yuriko Matsuzaki, and Yutaka Kawakami, and Naotaka Shibagaki, and Shinji Shimada
March 2002, Journal of immunology (Baltimore, Md. : 1950),
Takashi Inozume, and Hiroshi Mitsui, and Takashi Okamoto, and Yuriko Matsuzaki, and Yutaka Kawakami, and Naotaka Shibagaki, and Shinji Shimada
July 2009, Urology,
Takashi Inozume, and Hiroshi Mitsui, and Takashi Okamoto, and Yuriko Matsuzaki, and Yutaka Kawakami, and Naotaka Shibagaki, and Shinji Shimada
April 2003, European journal of immunology,
Takashi Inozume, and Hiroshi Mitsui, and Takashi Okamoto, and Yuriko Matsuzaki, and Yutaka Kawakami, and Naotaka Shibagaki, and Shinji Shimada
July 2003, World journal of gastroenterology,
Takashi Inozume, and Hiroshi Mitsui, and Takashi Okamoto, and Yuriko Matsuzaki, and Yutaka Kawakami, and Naotaka Shibagaki, and Shinji Shimada
August 2001, Journal of pediatric surgery,
Takashi Inozume, and Hiroshi Mitsui, and Takashi Okamoto, and Yuriko Matsuzaki, and Yutaka Kawakami, and Naotaka Shibagaki, and Shinji Shimada
April 2010, Gene therapy,
Takashi Inozume, and Hiroshi Mitsui, and Takashi Okamoto, and Yuriko Matsuzaki, and Yutaka Kawakami, and Naotaka Shibagaki, and Shinji Shimada
April 2010, Biochemical and biophysical research communications,
Takashi Inozume, and Hiroshi Mitsui, and Takashi Okamoto, and Yuriko Matsuzaki, and Yutaka Kawakami, and Naotaka Shibagaki, and Shinji Shimada
February 2000, Blood,
Takashi Inozume, and Hiroshi Mitsui, and Takashi Okamoto, and Yuriko Matsuzaki, and Yutaka Kawakami, and Naotaka Shibagaki, and Shinji Shimada
July 2018, Cytometry. Part B, Clinical cytometry,
Takashi Inozume, and Hiroshi Mitsui, and Takashi Okamoto, and Yuriko Matsuzaki, and Yutaka Kawakami, and Naotaka Shibagaki, and Shinji Shimada
March 2004, American journal of hematology,
Copied contents to your clipboard!